Effects of STN-DBS on Depression and Cognitive Status Dementia in Patients with Parkinson’s Disease

Vahid Ghadri, Omid Rezael, Muhammad Ebrahimzadeh Mousavi, Mansour Parvaresh, Sadegh Ghadri

Abstract


Non-motor symptoms such as depression and in later phases dementia are common features of Parkinson’s disease. For the first time in Iran, the present study aims to examine the effects of deep brain stimulation of the subthalamic nucleys (STN-DBS) on cognition and mood through neuropsychological assessment of patients with Parkinson’s disease. Stimulation of the subthalamic has no negative effect on the short-term cognitive status of patients with Parkinson’s disease, and improves depression. Precise psychological evaluation helps better recognition of the effects of this kind of surgery, which may be useful in providing quality services for those who will be candidates for this surgery in the future.

Keywords


Parkinson’s disease; DBS; STN; neuropsychological; depression; cognition

Full Text:

PDF

References


Giladi N, Mcdermott MP, Fahn S, Przedborski S, Jankovic J, et al. Parkinson Study Group. Freezing of gait in PD Prospective assessment in the DATATOP cohort. Neurology 2001:26;56:1712-21.

Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Movement disorders 2008;23:837-44.

Moazzami, D. An introduction to neuropsychology. Tehran Samt 2013, p.74-77.

Deuschl G, Schade Brittinger C, Krack P, Volkmann J, Schafer H, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. New England Journal of Medicine 2006;31;355:896-908.

Williams A, Gill S, Varma T, Jenkinson C, Quinn N, et al. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol (NLM) 2010;30;9:581-91.

Okun MS, Zeilman PR. Parkinson’s disease: Guide to deep brain stimulation therapy. National Parkinson Foundation (NPF) 2014;23:837

Mohammadkhani P, Dobson KS, Amiri M, Hosseini Ghafari F. Psychometric properties of the Brief Symptom Inventory in a sample of recovered Iranian depressed patients. International Journal of Clinical and Health Psychology (IJCHP) 2010;10:3.

Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. Journal of the American Geriatrics Society(AGS) 1975;1:433-41.

Salehi H, Nezakatolhoseini M, Azadian A. Attention Deficit During Dual-Task Performance in Alzheimer’s Disease Patients. Iranian Journal Ageing(IGA) 2014;15:88-96.

Sa’atian, M., & Parvaresh, M. Determining the appropriate place of DBS in patients with dystonia. (Unpublished doctoral dissertation). Iran University of Medical Sciences(IUMS), Tehran, Iran 2013;28:18.

Tabibkhooei A, Parvaresh M. Determining the appropriate place of STN for DBS in patients with Parkinson’s disease. (Unpublished doctoral dissertation) Iran University of Medical Sciences, Tehran, Iran 2013;4:217.

Miyasaki JM, Shannon K, Voon V, Ravina B, Kleiner fisman G, et al. Practice Parameter Evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology (AAN) Neurology 2006;11;66:996-1002.

Calabresi PA, Giovannoni G, Confavreux C, Galetta SL, Havrdova E, et al. The incidence and significance of anti-natalizumab antibodies Results from AFFIRM and SENTINEL. Neurology 2007;2;69:1391-403.

Castelli L, Perozzo P, Zibetti M, Crivelli B, Morabito U, Lanotte M , et al. Chronic deep brain stimulation of the subthalamic nucleus for Parkinson’s disease: effects on cognition, mood, anxiety and personality traits. European neurology 2006;55:136-44.

Witt K, Daniels C, Reiff J, Krack P, Volkmann J, et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease a randomised, multicentre study. The Lancet Neurology 2008;31;7:605-14.

Voon V, Moro E, Saint-Cyr JA, Lozano AM, Lang AE. Psychiatric Symptoms Following Surgery for Parkinson's Disease with an Emphasis. Behavioral Neurology of Movement Disorders 2005;96:130.

Hughes TA, Ross HF, Musa S, Bhattacherjee S, Nathan RN, Mindham RH , et al. A 10-year study of the incidence of and factors predicting dementia in Parkinson’s disease. Neurology 2000;25;54:1596-603.

Morales DA, Vives-Gilabert Y, Gómez-Ansón B, Bengoetxea E, Larrañaga P, Bielza C, et al. Predicting dementia development in Parkinson's disease using Bayesian network classifiers. Psychiatry Research: NeuroImaging 2013;30;213:92-8.

Mehanna R, Lai EC. Deep brain stimulation in Parkinson’s disease. Translational neurodegeneration 2013;18;2:22.

Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson9s disease?. Journal of Neurology, Neurosurgery & Psychiatry 2000;1;69:308-




DOI: https://doi.org/10.33258/birex.v1i1.172

Article Metrics

Abstract view : 326 times
PDF - 262 times

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
 

 

Statcounter for Budapest International Research in Exact Sciences (BirEx Journal)